Philipp K. Haber
Berlin, BE 13353, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Biological selection explains survival differences in perihilar cholangiocarcinoma: Post-hoc application of the mayo criteria to a resection cohort.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: February 12, 2026
Proteomic profiling of colorectal liver metastases reveals histopathological response-specific molecular signatures of chemotherapy efficacy.
Journal: Journal of translational medicine
Published: December 06, 2025
Immune biomarkers predicting response to G-CSF in acute-on-chronic liver failure: results from a GRAFT trial sub-study.
Journal: Hepatology international
Published: November 14, 2025
Differential effects of preoperative cholangitis and biliary stenting in long-term survival of patients undergoing surgery for perihilar cholangiocarcinoma.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: October 30, 2025
Influencing factors and results of conversions in minimally invasive liver surgery : A single-center analysis of over 1200 consecutive cases
Journal: Chirurgie (Heidelberg, Germany)
Published: August 01, 2025
Adherence to Multidisciplinary Tumor Board Decisions Determines Long-term Survival in Patients with Hepatocellular Carcinoma.
Journal: Annals of surgery
Published: April 26, 2025
Extracellular NAD+ levels are associated with CD203a expression on Th17 cells and predict long-term recurrence-free survival in hepatocellular carcinoma.
Journal: Journal of cancer research and clinical oncology
Published: January 13, 2025
Solidifying local ablation in the treatment of small-size colorectal liver metastasis.
Journal: The Lancet. Oncology
Published: December 15, 2024
Metabolomic liquid biopsy dynamics predict early-stage HCC and actionable candidates of human hepatocarcinogenesis.
Journal: JHEP reports : innovation in hepatology
Published: October 14, 2024
Integrating the new systemic treatment landscape and surgical therapy in hepatocellular carcinoma.
Journal: Turkish journal of surgery
Published: March 07, 2024
Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma.
Journal: Journal of hepatology
Published: February 02, 2024
Last Updated: 09/26/2026